{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:10:21Z","timestamp":1792887021773,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.clgc.2025.102323","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T15:17:37Z","timestamp":1742397457000},"page":"102323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Impact of TP53 Alterations on Clinical Outcomes in Penile Squamous Cell Carcinoma"],"prefix":"10.1016","volume":"23","author":[{"given":"Yajian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziru","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhannan","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2176-5419","authenticated-orcid":false,"given":"Gang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2025.102323_bib0001","first-page":"e117","article-title":"Incidence of penile cancer worldwide: systematic review and meta-analysis","volume":"41","author":"Montes Cardona","year":"2017","journal-title":"Rev Panam Salud Publica"},{"issue":"1","key":"10.1016\/j.clgc.2025.102323_bib0002","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-021-00246-5","article-title":"Penile cancer","volume":"7","author":"Thomas","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.clgc.2025.102323_bib0003","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/ncpuro0751","article-title":"Prognostic factors in squamous cell carcinoma of the penis","volume":"4","author":"Novara","year":"2007","journal-title":"Nat Clin Pract Urol"},{"issue":"2","key":"10.1016\/j.clgc.2025.102323_bib0004","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00345-008-0310-z","article-title":"Multimodality therapy in penile cancer: when and which treatments?","volume":"27","author":"Pagliaro","year":"2009","journal-title":"World J Urol"},{"key":"10.1016\/j.clgc.2025.102323_bib0005","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/593751","article-title":"Current and future strategies in the diagnosis and management of penile cancer","volume":"2011","author":"Lawindy","year":"2011","journal-title":"Adv Urol"},{"issue":"3","key":"10.1016\/j.clgc.2025.102323_bib0006","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.juro.2010.10.058","article-title":"Identification of high risk pathological node positive penile carcinoma: value of preoperative computerized tomography imaging","volume":"185","author":"Graafland","year":"2011","journal-title":"J Urol"},{"issue":"6569","key":"10.1016\/j.clgc.2025.102323_bib0007","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/380079a0","article-title":"Telomerase activation by the E6 gene product of human papillomavirus type 16","volume":"380","author":"Klingelhutz","year":"1996","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.clgc.2025.102323_bib0008","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1016\/j.clgc.2019.10.014","article-title":"PD-L1 and p16 expression in penile squamous cell carcinoma from an endemic region","volume":"18","author":"De Bacco","year":"2020","journal-title":"Clin Genitourin Cancer"},{"issue":"5","key":"10.1016\/j.clgc.2025.102323_bib0009","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1470-2045(07)70137-7","article-title":"Molecular and genetic pathways in penile cancer","volume":"8","author":"Kayes","year":"2007","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.clgc.2025.102323_bib0010","doi-asserted-by":"crossref","first-page":"594","DOI":"10.6004\/jnccn.2013.0075","article-title":"Penile cancer: Clinical practice Guidelines in oncology","volume":"11","author":"Clark","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"10.1016\/j.clgc.2025.102323_bib0011","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/bioinformatics\/btv024","article-title":"Ultrafast SNP analysis using the Burrows-Wheeler transform of short-read data","volume":"31","author":"Kimura","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.clgc.2025.102323_bib0012","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3389\/fgene.2019.00736","article-title":"Sentieon DNASeq variant calling workflow demonstrates strong computational performance and accuracy","volume":"10","author":"Kendig","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.clgc.2025.102323_bib0013","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13029-016-0060-z","article-title":"PureCN: copy number calling and SNV classification using targeted short read sequencing","volume":"11","author":"Riester","year":"2016","journal-title":"Source Code Biol Med"},{"issue":"7463","key":"10.1016\/j.clgc.2025.102323_bib0014","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.clgc.2025.102323_bib0015","article-title":"OncoKB: A precision oncology knowledge base","volume":"2017","author":"Chakravarty","year":"2017","journal-title":"JCO Precis Oncol"},{"issue":"2","key":"10.1016\/j.clgc.2025.102323_bib0016","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic signaling pathways in the cancer genome atlas","volume":"173","author":"Sanchez-Vega","year":"2018","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.clgc.2025.102323_bib0017","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/MOU.0000000000000719","article-title":"Neoadjuvant chemotherapy for lymph node-positive penile cancer: current evidence and knowledge","volume":"30","author":"Bandini","year":"2020","journal-title":"Curr Opin Urol"},{"issue":"4","key":"10.1016\/j.clgc.2025.102323_bib0018","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/bju.13686","article-title":"Factors associated with regional recurrence after lymph node dissection for penile squamous cell carcinoma","volume":"119","author":"Reddy","year":"2017","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.clgc.2025.102323_bib0019","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.eururo.2024.03.038","article-title":"Single-cell atlas of penile cancer reveals TP53 mutations as a driver of an aggressive phenotype, irrespective of Human papillomavirus status, and provides clues for treatment personalization","volume":"86","author":"Elst","year":"2024","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.clgc.2025.102323_bib0020","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/ijc.32373","article-title":"Mutational landscape of penile squamous cell carcinoma in a Chinese population","volume":"145","author":"Wang","year":"2019","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.clgc.2025.102323_bib0021","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00432-021-03514-9","article-title":"TERT promoter mutations in penile squamous cell carcinoma: high frequency in non-HPV-related type and association with favorable clinicopathologic features","volume":"147","author":"Kim","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.clgc.2025.102323_bib0022","article-title":"Correlation between the evolution of somatic alterations during lymphatic metastasis and clinical outcome in penile squamous cell carcinoma","volume":"11","author":"Cao","year":"2021","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.clgc.2025.102323_bib0023","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","article-title":"Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer","volume":"171","author":"Puram","year":"2017","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.clgc.2025.102323_bib0024","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/s41379-019-0429-z","article-title":"CD274 (PD-L1), CDKN2A (p16), TP53, and EGFR immunohistochemical profile in primary, recurrent and metastatic vulvar cancer","volume":"33","author":"L\u00e9rias","year":"2020","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.clgc.2025.102323_bib0025","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.cell.2020.05.039","article-title":"Multimodal analysis of composition and spatial architecture in human squamous cell carcinoma","volume":"182","author":"Ji","year":"2020","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.clgc.2025.102323_bib0026","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.pathol.2023.10.010","article-title":"High tumour mutational burden is associated with strong PD-L1 expression, HPV negativity, and worse survival in penile squamous cell carcinoma: an analysis of 165 cases","volume":"56","author":"Hrudka","year":"2024","journal-title":"Pathology"},{"issue":"12","key":"10.1016\/j.clgc.2025.102323_bib0027","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.48002","article-title":"Genomic profiles and clinical outcomes of penile squamous cell carcinoma with elevated tumor mutational burden","volume":"6","author":"Necchi","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.clgc.2025.102323_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.152881","article-title":"High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular features","volume":"216","author":"Liu","year":"2020","journal-title":"Pathol Res Pract"},{"issue":"8","key":"10.1016\/j.clgc.2025.102323_bib0029","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/jamaoncol.2022.1981","article-title":"Association of high tumor mutation burden in non-small cell lung cancers with increased immune infiltration and improved clinical outcomes of PD-L1 blockade across PD-L1 expression levels","volume":"8","author":"Ricciuti","year":"2022","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.clgc.2025.102323_bib0030","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.eururo.2023.02.027","article-title":"European Association of Urology-American Society of Clinical Oncology collaborative guideline on penile cancer: 2023 update","volume":"83","author":"Brouwer","year":"2023","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.clgc.2025.102323_bib0031","doi-asserted-by":"crossref","first-page":"200.e11","DOI":"10.1016\/j.urolonc.2022.02.014","article-title":"Effectiveness and safety of adjuvant chemotherapy compared to neoadjuvant chemotherapy in patients with penile cancer and positive lymph nodes regarding overall survival and free disease survival: a systematic review and meta-analysis","volume":"40","author":"Paz Rojas","year":"2022","journal-title":"Urol Oncol"},{"issue":"8","key":"10.1016\/j.clgc.2025.102323_bib0032","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41585-022-00617-x","article-title":"Immune-based therapies in penile cancer","volume":"19","author":"Joshi","year":"2022","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.clgc.2025.102323_bib0033","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.humpath.2016.09.003","article-title":"Immune-checkpoint status in penile squamous cell carcinoma: a North American cohort","volume":"59","author":"Cocks","year":"2017","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1016\/j.clgc.2025.102323_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103481","article-title":"Penile cancer: ESMO-EURACAN clinical practice guideline for diagnosis, treatment and follow-up","volume":"9","author":"Muneer","year":"2024","journal-title":"ESMO Open"},{"issue":"9","key":"10.1016\/j.clgc.2025.102323_bib0035","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/modpathol.2011.85","article-title":"Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis","volume":"24","author":"Yemelyanova","year":"2011","journal-title":"Mod Pathol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325000242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325000242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T07:25:38Z","timestamp":1754551538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767325000242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1558767325000242"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102323","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of TP53 Alterations on Clinical Outcomes in Penile Squamous Cell Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102323","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102323"}}